The North America Patient Monitoring Devices Market is witnessing significant growth due to rising healthcare expenditures, increasing prevalence of chronic diseases, technological advancements, and the growing geriatric population. The market size was valued at USD 11,100 Million in 2025 and is expected to reach USD 24,200 Million by 2035, growing at a CAGR of 7.5% from 2024 to 2035.
The economic impact of tariffs on "North America Patient Monitoring Devices Market".
Market Growth Drivers
Rising Incidence of Chronic Diseases: The increasing prevalence of chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders in North America is driving the demand for patient monitoring devices. According to Medtronic, chronic diseases account for 75% of healthcare spending in the US, triggering higher adoption of continuous glucose monitors, cardiac monitors, and other remote monitoring solutions. This trend is encouraging hospitals and ambulatory surgical centers to invest in advanced monitoring technologies to enhance patient outcomes and reduce readmission rates.
Accelerating Technological Innovation: Companies such as GE Healthcare and Philips Healthcare are introducing next-generation patient monitoring devices equipped with AI-powered analytics, wireless connectivity, and interoperability features. The integration of wearable technologies and mobile health applications supports real-time patient data tracking, enabling healthcare professionals to make quicker clinical decisions. These innovations also support at-home patient monitoring, aligning with the shift towards value-based care and personalized healthcare.
Market Trends
Expanding Telehealth and Remote Monitoring: The surge in telehealth adoption due to the COVID-19 pandemic has persisted, increasing demand for remote patient monitoring solutions. Organizations like Abbott Laboratories have launched platforms that provide continuous patient data access for clinicians outside traditional healthcare settings. These trends facilitate improved chronic disease management while minimizing in-person visits, lowering infection risk, and increasing the efficiency of healthcare delivery.
Integration of AI and IoT: Leading companies, including Siemens Healthineers, are integrating Artificial Intelligence (AI) and Internet of Things (IoT) technologies with patient monitoring devices. These advancements allow for predictive analytics, personalized alerts, and streamlined data management, enhancing clinical decision-making. AI-driven solutions also facilitate early detection of deteriorating health conditions, reducing response time and improving patient safety.
Market Opportunities
Expansion in Home Healthcare: With ageing populations and a shift towards home-based care, companies such as ResMed are capitalizing on the demand for portable, easy-to-use patient monitoring devices, aiming to address gaps in continuous care for chronic disease patients.
Government Initiatives and Reimbursements: Regulatory support and reimbursement schemes, particularly in the United States and Canada, are encouraging the adoption of digital patient monitoring solutions by hospitals and clinics, creating new growth avenues for manufacturers.
North America Patient Monitoring Devices Market Revenue (USD Million), 2020-2035
The market revenue chart demonstrates a steady growth trajectory for the North America Patient Monitoring Devices Market from 2020 to 2035. Starting at USD 6,500 Million in 2020, the revenue grows to USD 8,100 Million by 2023. A marked acceleration occurs post-2024, reaching USD 11,100 Million in 2025 and peaking at USD 24,200 Million by 2035. This expansion is driven by increased adoption of remote monitoring technologies, growing prevalence of chronic diseases, and favorable regulatory frameworks. The chart reflects significant market opportunities for device manufacturers and healthcare providers, highlighting a compound annual growth rate of 7.5%.
North America Patient Monitoring Devices Market Share by Region (%) - 2025
The pie chart for 2025 illustrates the regional share distribution of the North America Patient Monitoring Devices Market. The United States dominates with 72% of the total market, reflecting its advanced healthcare infrastructure and higher adoption rates. Canada follows with 18%, benefitting from increasing government healthcare spending. Mexico holds an 8% share, while the rest of North America collectively accounts for 2%. The regional disparity highlights the need for improved market penetration strategies, particularly in Canada and Mexico, to fully leverage future growth opportunities and meet rising demand in under-served areas.
Recent Developments in the North America Patient Monitoring Devices Market
In February 2024, Philips Healthcare launched its newest wearable biosensor in the US, designed for hospital and home settings. The biosensor measures respiratory rate, heart rate, and ambient temperature, automatically transmitting patient data to care teams via cloud connectivity. This launch aims to reduce hospital workload and provide real-time patient status, particularly for those with chronic diseases.
In March 2024, Medtronic announced a partnership with Teladoc Health to integrate remote patient monitoring with virtual care solutions. This collaboration allows for seamless data sharing between patients using Medtronic’s at-home monitoring devices and physicians conducting virtual consultations, improving chronic disease management and post-acute care follow-up.
In April 2024, Abbott Laboratories received FDA clearance for its next-generation glucose monitoring system, FreeStyle Libre 4, which features augmented accuracy and continuous Bluetooth transmission. The device is set to expand the market reach for diabetes management solutions and promote ease of use for North American patients with diabetes.
Press Releases